ArticleFrontiers in neurology2025

JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab.

Qi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.